ARNA Genomics is a seed startup. Status: possibledead.
ARNA Genomics is a startup founded in 2013 based in the United States. Its most recent tracked round is Seed.
ARNA Genomics is a biotechnology company focused on developing early cancer detection technologies using liquid biopsy multiomics. Their tests analyze cell-free DNA in blood plasma to diagnose cancer, with flagship products including ARNA-1 for general oncological disease detection and ARNA Breast for breast cancer.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.